SCHEMBL3757156

SCHEMBL3757156

CN(C)c1ccc(/C=C2/C(=O)NC(=S)N(c3ccccc3F)C2=O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.62
MEN1 O00255 10/20 0.62
KMT2A Q03164 10/20 0.62
ALDH1A1 P00352 8/20 0.62
HPGD P15428 5/20 0.62
NPSR1 Q6W5P4 5/20 0.62
PKM P14618 4/20 0.62
MAPK1 P28482 4/20 0.62
LMNA P02545 3/20 0.62
POLB P06746 3/20 0.62
L3MBTL1 Q9Y468 3/20 0.62
MCL1 Q07820 2/20 0.62
TP53 P04637 2/20 0.62
HTT P42858 2/20 0.61
RECQL P46063 2/20 0.61
THRB P10828 2/20 0.61
APP P05067 5/20 0.51
SNCA P37840 5/20 0.51
KDM4E B2RXH2 2/20 0.49
PDGFRB P09619 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3757161 1.00 MAPT (0.62) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL3757164 1.00 MAPT (0.62) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL3763734 0.84 MEN1 (0.53) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL3763736 0.84 MEN1 (0.53) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL3763740 0.84 MEN1 (0.53) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL12218472 0.84 MAPT (0.61) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL16979814 0.77 KMT2A (0.64) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL16967441 0.77 KMT2A (0.64) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL16967440 0.77 KMT2A (0.64) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL124459 0.77 ITGA4 (0.58) MAPTMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE BURHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-12-02 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE UNITED STATES GOVERNMENT 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203236-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 MAPT 4500/4885MEN1 3665/4885KMT2A 3767/4885
US-20100305121-A1 NOVEL ANTAGONISTS OF THE HUMAN FATTY ACID SYNTHASE THIOESTERASE FADS2, ACOT7, FADS1 MAPT 4500/4885MEN1 3665/4885KMT2A 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.